Drug Pipeline

Floxuridine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
1
Phase 3
4
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-16 NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of…		 Trial sites expanded: 39 -> 60 locations
Active Studies by Phase
Phase 3
1
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05863195 Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of… Metastatic Colorectal Carcinoma Recruiting
Phase 2
NCT06313203 HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic… Intrahepatic Cholangiocarcinoma Recruiting
NCT04891289 Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone… Intrahepatic Cholangiocarcinoma Recruiting
NCT05286814 PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for… Metastatic Colorectal Cancer (Mcrc) Recruiting
NCT00492999 Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination… Colorectal Cancer Active, Not Recruiting
Sponsors Running Floxuridine Trials
Memorial Sloan Kettering Cancer Center (2) National Cancer Institute (NCI) (1) ECOG-ACRIN Cancer Research Group (1) Oslo University Hospital (1)
Disease Areas
Colorectal Cancer (3) Cholangiocarcinoma (3)
Get alerts when Floxuridine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free